Get alerts when CME reports next quarter
Set up alerts — freeCME Group’s stock rose 7.1% following Q2 2026 results driven by revenue and earnings modestly ahead of expectations and strong volume growth. Market rewarded the company’s continued innovation and robust capital efficiencies despite only slight year-over-year growth in key financial metrics.
See CME alongside your other holdings
Add to your portfolio — freeTrack CME Group Inc. in your portfolio with real-time analytics, dividend tracking, and more.
View CME Analysis